Efficacy and Molecular Mechanisms of Differentiated Response to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Models of p53-Mutated Triple-Negative Breast Cancer

PURPOSE: Triple-negative breast cancer (TNBC) is a subtype associated with poor prognosis and for which there are limited therapeutic options. The purpose of this study was to evaluate the efficacy of ENMD-2076 in p53-mutated TNBC patient-derived xenograft (PDX) models and describe patterns of termi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ionkina, Anastasia A., Tentler, John J., Kim, Jihye, Capasso, Anna, Pitts, Todd M., Ryall, Karen A., Howison, Rebekah R., Kabos, Peter, Sartorius, Carol A., Tan, Aik Choon, Eckhardt, S. Gail, Diamond, Jennifer R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430301/
https://www.ncbi.nlm.nih.gov/pubmed/28555173
http://dx.doi.org/10.3389/fonc.2017.00094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430301/
https://www.ncbi.nlm.nih.gov/pubmed/28555173
http://dx.doi.org/10.3389/fonc.2017.00094

Ejemplares similares